Tyree IHealthE

Morning tea with IHealthE

Nurturing Industry Relationships

Published on the 27 April 2023

The recent morning tea session highlighted the integral role MedTech companies and enterprises play within the MedTech ecosystem. These industry leaders are responsible for developing and delivering products and services that directly benefit patients, caregivers, and clinicians. They bring a deep understanding of regulatory and business realities involved in bringing products to market, as well as insight into the unmet needs of clinicians, institutions, and end-users.

Researchers and innovators, on the other hand, contribute cutting-edge technology and ideas that have the potential to transform clinical practice and improve patient outcomes. Despite the clear benefits of collaboration between university innovators and industry, establishing strong, enduring relationships that deliver sustained outcomes remains a challenge.

During the session, Dr Daneh Turner from GE Healthcare and Stuart Anderson from the Medical Technology Association of Australia shared their expertise on building relationships and forging successful partnerships with university innovators. Their insights provided attendees with practical strategies for fostering collaboration and driving innovation in the MedTech sector.
Date

27 April 2023

Venue

UNSW Sydney Atrium Space, Level 2 Biological Sciences Building Sydney, NSW 2052

Format

In person

Speakers

Dr Daneh Turner is the Regional Research Manager for Australia and New Zealand at GE Healthcare. Her role is to facilitate partnerships with world class academic institutions and industry partners to support research and development. Prior to working at GE Healthcare, Dr Turner worked at Macquarie University as a Senior Lecturer in the field of orthopaedic biomechanics; and previous to that as a partner and Biomedical Specialist in a consulting firm. Working closely with clinical and industry partners, she and her team used advanced computational modelling techniques, imaging technologies and clinical research methods to answer questions related to joint arthroplasty and surgical reconstruction, and improvements in orthopaedic implant design.

Dr Turner has undergraduate training as a mechanical engineer and postgraduate training in biomedical engineering from UNSW.

Stuart Anderson supports the Medical Technology Association of Australia (MTAA) with delivering the Clinical Translation and Commercialisation – Medtech (CTC-M) Program on behalf of MTPConnect as part of a broader industry development and technology commercialisation initiative at the MTAA. He is passionate about growing Australia’s medical device innovation ecosystem toward the goal of improved patient otucomes across research translation, rapid growth start-ups and our nascent sovereign manufacturing capability by enhancing connections with global medical device companies and disciplined investors. He brings to this role a blend of equity capital market, including venture capital and private equity, strategic insights, innovation consulting, product development and entrepreneurial experiences.

Dr Ian Goon has a background in scientific research, developing nano-materials for biosensing applications and subsequently spent 4 years in a commercially focused-role as a strategy consultant with The Boston Consulting Group in Southeast Asia. Ian co-founded a health technology startup focused on building digital tools for healthcare research projects, prior to joining Tyree IHealthE. His work included leading the development and implementation of technology platforms for the South Asia Biobank (South Asia and UK) and the SG100K population health study in Singapore. Ian holds a BEng (Chemical) and Ph.D from UNSW and obtained an MPhil in Bioscience Enterprise from the University of Cambridge as a Chevening scholar.